Top compounds associated with response to PLD4


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan gCSI pan-cancer AAC -0.00055 1
mRNA Mitomycin-C GDSC1000 pan-cancer AAC 0.00028 1
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.00028 1
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.00035 1
Download CSV